| Financial Year |
March 31 2023 |
| Monetary Funds |
316,347,832.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,221,176.82 |
| Accounts Receivable |
1,951,755,929.27 |
| Advances to Suppliers |
59,835,555.76 |
| Other Receivables |
189,230,083.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
250,053,355.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,335,541.46 |
| Total Current Assets |
2,842,804,483.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
684,648.98 |
| Investment Properties |
590,779,844.14 |
| Fixed Assetes |
1,432,015,627.13 |
| Under-construction Projects |
747,605,881.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
526,317,207.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,280,877.54 |
| Deferred Income Tax Assets |
283,666,121.37 |
| Other Non-Current Assets |
8,026,707.00 |
| Sub-Total of Non-Current Assets |
3,650,998,231.00 |
| Total Assets |
6,493,802,714.16 |
| Short-Term Loans |
1,195,641,680.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
697,085,401.37 |
| Accounts Payable |
847,740,181.59 |
| Accounts Received In Advance |
2,985,656.22 |
| Employee Compensation Payable |
80,297,171.66 |
| Taxes Payable |
33,061,584.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
510,478,093.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
406,752,104.53 |
| Other Current Liabilities |
13,155,506.29 |
| Sub-Total of Current Liabilities |
3,885,867,512.62 |
| Long-term Loans |
633,402,660.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
104,582,474.22 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,761,556.57 |
| Deferred Income Tax Liabilities |
46,894,712.84 |
| Other Non-Current Liabilities |
103,113,478.48 |
| Sub-Total of Non-Current Liabilities |
898,334,215.17 |
| Total Liabilities |
4,784,201,727.79 |
| Paid-In Capital(Or Share Stock) |
431,736,425.00 |
| Capital Surplus |
751,164,571.70 |
| Surplus Reserve |
26,701,529.04 |
| LESS:Treasury Stock |
20,523,452.87 |
| Undistributed Profits |
342,145,862.64 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,709,600,986.37 |
| Owner's Equity（Stockholder's Equity） |
1,709,600,986.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,493,802,714.16 |
